{"groups":[{"description":"Placebo","id":"FG000","title":"Placebo"},{"description":"Nivolumab 240mg IV Q2W","id":"FG001","title":"Nivolumab"}],"periods":[{"dropWithdraws":[{"reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"1"}],"type":"AE unrelated to study Drug"},{"reasons":[{"groupId":"FG000","numSubjects":"2"},{"groupId":"FG001","numSubjects":"1"}],"type":"Participant withdrew consent"},{"reasons":[{"groupId":"FG000","numSubjects":"5"},{"groupId":"FG001","numSubjects":"0"}],"type":"No Longer meets study criteria"},{"reasons":[{"groupId":"FG000","numSubjects":"1"},{"groupId":"FG001","numSubjects":"0"}],"type":"other reasons"}],"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"356"},{"groupId":"FG001","numSubjects":"353"}],"comment":"= Randomized","type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"348"},{"groupId":"FG001","numSubjects":"351"}],"comment":"= Treated","type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"8"},{"groupId":"FG001","numSubjects":"2"}],"type":"NOT COMPLETED"}],"title":"Randomized"},{"dropWithdraws":[{"reasons":[{"groupId":"FG000","numSubjects":"20"},{"groupId":"FG001","numSubjects":"21"}],"type":"Ongoing Treatment"},{"reasons":[{"groupId":"FG000","numSubjects":"147"},{"groupId":"FG001","numSubjects":"90"}],"type":"Disease Recurrence"},{"reasons":[{"groupId":"FG000","numSubjects":"8"},{"groupId":"FG001","numSubjects":"49"}],"type":"Study Drug Toxicity"},{"reasons":[{"groupId":"FG000","numSubjects":"1"},{"groupId":"FG001","numSubjects":"0"}],"type":"Death"},{"reasons":[{"groupId":"FG000","numSubjects":"15"},{"groupId":"FG001","numSubjects":"16"}],"type":"AE unrelated to study drug"},{"reasons":[{"groupId":"FG000","numSubjects":"4"},{"groupId":"FG001","numSubjects":"19"}],"type":"Request to discontinue treatment"},{"reasons":[{"groupId":"FG000","numSubjects":"7"},{"groupId":"FG001","numSubjects":"5"}],"type":"Participant withdrew consent"},{"reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"1"}],"type":"Lost to Follow-up"},{"reasons":[{"groupId":"FG000","numSubjects":"1"},{"groupId":"FG001","numSubjects":"0"}],"type":"Maximum clinical benefit"},{"reasons":[{"groupId":"FG000","numSubjects":"3"},{"groupId":"FG001","numSubjects":"0"}],"type":"No longer meets study criteria"},{"reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"1"}],"type":"Administrative Reason by sponsor"},{"reasons":[{"groupId":"FG000","numSubjects":"10"},{"groupId":"FG001","numSubjects":"6"}],"type":"Other Reasons"}],"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"348"},{"groupId":"FG001","numSubjects":"351"}],"comment":"= Randomized and Treated","type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"132"},{"groupId":"FG001","numSubjects":"143"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"216"},{"groupId":"FG001","numSubjects":"208"}],"type":"NOT COMPLETED"}],"title":"Treatment Period"}],"preAssignmentDetails":"709 Participants Randomized, 699 Treated"}